Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online November 2, 2018.
Article Versions
- You are currently viewing a previous version of this article (November 2, 2018 - 07:00).
- View the most recent version of this article
Copyright & Usage
Copyright © 2018 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Thomas Wilson1,
- Mary-Ann Xavier1,
- James Knight1,
- Stefan Verhoog1,
- Julia Baguña Torres1,
- Michael Mosley1,
- Samantha Hopkins1,
- Sheena Wallington1,
- Danny Allen1,
- Veerle Kersemans1,
- Rebekka Hueting2,
- Sean Smart1,
- Veronique Gouverneur3 and
- Bart Cornelissen1
- 1 University of Oxford, United Kingdom;
- 2 CRUK/MRC Oxford Institute for Radiation Oncology, United Kingdom;
- 3 University of Oxford, United Kingdom
- For correspondence or reprints contact: Bart Cornelissen, University of Oxford, Department of Oncology, Radiobiology Research Insitute, Churchill Hospital, Headington, Oxford, OX OX3 7LJ, United Kingdom. E-mail: bart.cornelissen@oncology.ox.ac.uk
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- [123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
- [18F]-Labeled PARP-1 PET Imaging of PSMA Targeted Alpha Particle Radiotherapy Response
- Molecular Imaging: PARP-1 and Beyond
- PARP Inhibitors in Cancer Diagnosis and Therapy
- Preclinical and first-in-human-brain-cancer applications of [18F]poly-(ADP-ribose) polymerase inhibitor PET/MR
- Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
- PARP1/2 imaging with 18F-PARPi in patients with head and neck cancer
- Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer